Literature DB >> 8795584

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.

A H Lee1, L C Happerfield, R R Millis, L G Bobrow.   

Abstract

The significance of inflammation in carcinoma of the breast is controversial. Little attention has been paid to different patterns of inflammation or inflammation associated with different histological types of carcinoma. We have looked at the pattern of inflammation in 123 invasive mammary carcinomas (including 46 lobular), and characterised the inflammatory cells with immunohistochemistry in 21. We found different patterns of inflammation in ductal and lobular carcinoma. Diffuse inflammation was seen more in ductal carcinoma, particularly of high grade, and was predominantly composed of macrophages and T cells. It was associated with necrosis, but the correlation was weak, suggesting that other factors are important. Perilobular inflammation was seen most frequently in lobular and high-grade ductal carcinomas, particularly at the tumour edge. Perivascular inflammation was also largely at the tumour edge, but was not more common in any tumour type. In contrast to the diffuse inflammation, the perivascular and perilobular inflammation was composed of T and B cells. Normal lobules at the tumour edge showed consistent expression of HLA-DR, whereas lobules away from the tumour were negative. A combination of perilobular and perivascular inflammation composed of B and T cells with epithelial expression of HLA-DR mimicking lymphocytic lobulitis was seen more frequently in lobular than ductal carcinoma.

Entities:  

Mesh:

Year:  1996        PMID: 8795584      PMCID: PMC2074701          DOI: 10.1038/bjc.1996.438

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Periductal lymphoid infiltrations in mammary tissue.

Authors:  M M BLACK; F D SPEER
Journal:  AMA Arch Pathol       Date:  1955-10

2.  Macrophage infiltration of breast tumours: a prospective study.

Authors:  I Lauder; W Aherne; J Stewart; R Sainsbury
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

3.  Lymphocytic lobulitis and carcinoma of the breast.

Authors:  A H Lee; R R Millis; L G Bobrow
Journal:  Histopathology       Date:  1996-01       Impact factor: 5.087

4.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

5.  Prognosis in breast cancer utilizing histologic characteristics of the primary tumor.

Authors:  M M Black; T H Barclay; B F Hankey
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

6.  Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis.

Authors:  S M Scholl; C Pallud; F Beuvon; K Hacene; E R Stanley; L Rohrschneider; R Tang; P Pouillart; R Lidereau
Journal:  J Natl Cancer Inst       Date:  1994-01-19       Impact factor: 13.506

7.  Tumor-host interrelationships in carcinoma of the female breast.

Authors:  K J Syrjänen; L H Hjelt
Journal:  Surg Gynecol Obstet       Date:  1978-07

8.  Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component.

Authors:  O T Lampejo; D M Barnes; P Smith; R R Millis
Journal:  Semin Diagn Pathol       Date:  1994-08       Impact factor: 3.464

Review 9.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

10.  The relative significance of prognostic factors in breast carcinoma.

Authors:  M R Alderson; I Hamlin; M D Staunton
Journal:  Br J Cancer       Date:  1971-12       Impact factor: 7.640

View more
  10 in total

Review 1.  Tumor-associated macrophages in breast cancer.

Authors:  Russell D Leek; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.

Authors:  Sofia Levva; Vassiliki Kotoula; Ioannis Kostopoulos; Kyriaki Manousou; Christos Papadimitriou; Kyriaki Papadopoulou; Sotiris Lakis; Kyriakos Koukoulias; Vasilios Karavasilis; George Pentheroudakis; Eufemia Balassi; Flora Zagouri; Ioannis G Kaklamanos; Dimitrios Pectasides; Evangelia Razis; Gerasimos Aravantinos; Pavlos Papakostas; Dimitrios Bafaloukos; Grigorios Rallis; Helen Gogas; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

3.  Angiogenesis and inflammation in invasive carcinoma of the breast.

Authors:  A H Lee; L C Happerfield; L G Bobrow; R R Millis
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

4.  Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model.

Authors:  Takeo Fujii; Jeremy Mason; Angela Chen; Peter Kuhn; Wendy A Woodward; Debu Tripathy; Paul K Newton; Naoto T Ueno
Journal:  Oncologist       Date:  2019-04-05

5.  Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.

Authors:  Anne Grote; Mahmoud Abbas; Nina Linder; Hans H Kreipe; Johan Lundin; Friedrich Feuerhake
Journal:  Diagn Pathol       Date:  2014-12-19       Impact factor: 2.644

6.  Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.

Authors:  Qiang He; Shuyin Xue; Qingbiao Wa; Mei He; Shuang Feng; Zhibing Chen; Wei Chen; Xinrong Luo
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

7.  The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer.

Authors:  A M Al Murri; M Hilmy; J Bell; C Wilson; A-M McNicol; A Lannigan; J C Doughty; D C McMillan
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

8.  Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.

Authors:  Hiroko Masuda; Keith A Baggerly; Ying Wang; Takayuki Iwamoto; Takae Brewer; Lajos Pusztai; Kazuharu Kai; Takahiro Kogawa; Pascal Finetti; Daniel Birnbaum; Luc Dirix; Wendy A Woodward; James M Reuben; Savitri Krishnamurthy; W Symmans; Steven J Van Laere; François Bertucci; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Breast Cancer Res       Date:  2013-11-25       Impact factor: 6.466

9.  In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium.

Authors:  J C L Alfonso; N S Schaadt; R Schönmeyer; N Brieu; G Forestier; C Wemmert; F Feuerhake; H Hatzikirou
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

10.  Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.

Authors:  Angie M Torres-Adorno; Heidi Vitrac; Yuan Qi; Lin Tan; Kandice R Levental; Yang-Yi Fan; Peiying Yang; Robert S Chapkin; Bedrich L Eckhardt; Naoto T Ueno
Journal:  Oncogene       Date:  2018-11-20       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.